4
Changes in Ownership
Attovia Therapeutics, Inc. Filed Acc 0001193125-26-342487
10% owner acquired 1,957,138 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Deep Track Biotechnology Master Fund, Ltd. 10% owner | 2026-08-06 | Conversion | +1,957,138 | 1,957,138 | D | ||
| Derivatives | |||||||
| Deep Track Biotechnology Master Fund, Ltd. 10% owner | 2026-08-06 | Conversion · Series C Redeemable Convertible Preferred Stock | −18,181,818 | D | |||
Loading xslF345X06/ownership.xml…